LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・ResMed Inc

ResMed Inc

Closed

Sector Healthcare

244.63 0.16

Buy Sell

Overview

Share price change

24h

Current

Min

243.54

Max

245.2

Key metrics
By Trading Economics
Income	-8.3M 292M
Sales	20M 1.2B
P/E Sector Avg	29.45 103.001
EPS	2.08
Profit margin	23.954
EBITDA	-67M 362M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-9 downside

Dividends
By Dow Jones
Next Earnings	24 paź 2024
Next Dividend date	19 wrz 2024

Market Stats
By TradingEconomics
Market Cap	72M 36B
Previous open	244.47
Previous close	244.63

News Sentiment

By Acuity

33%

67%

63 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

173.1 / 175.28 Support & Resistance

ResMed Inc Chart

Related News

24 cze 2024, 17:43 UTC

Major Market Movers

Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update

27 cze 2024, 16:01 UTC

Earnings

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

24 cze 2024, 17:28 UTC

Major Market Movers

ResMed, Inspire Medical Shares Down After Eli Lilly Provides Sleep Apnea Study Update

26 kwi 2024, 20:12 UTC

Earnings

These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

26 kwi 2024, 20:09 UTC

Earnings

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

26 kwi 2024, 14:01 UTC

Earnings

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes -- IBD

29 sty 2024, 05:30 UTC

Earnings

ResMed CEO: Weight-Loss Drugs Aren't Cutting Demand for Sleep Apnea Treatment -- Barrons.com

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

-9% downside

12 Months Forecast

Average 222.75 USD -9%

High 240 USD

Low 206 USD

Based on 10 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to ResMed Inc - Dist in the past 3 months.

Technical Score

By Trading Central

173.1 / 175.28Support & Resistance

Bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

63 / 365 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About ResMed Inc

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.